Tracey McCain
Compliance Officer at BLUEPRINT MEDICINES CORPORATION
Net worth: 6 M $ as of 2024-04-29
Tracey McCain active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 2016-09-05 | - |
| General Counsel | 2016-09-05 | - | |
| Corporate Secretary | 2016-09-05 | - | |
| KINIKSA PHARMACEUTICALS, LTD. | Director/Board Member | 2018-01-31 | - |
| Independent Dir/Board Member | 2018-01-31 | - |
Career history of Tracey McCain
Former positions of Tracey McCain
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOGEN, INC. | Director/Board Member | 2021-11-14 | 2024-02-11 |
| Independent Dir/Board Member | 2021-11-14 | 2024-02-11 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | General Counsel | 2015-12-31 | 2016-09-01 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 1997-04-30 | 2016-08-31 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Training of Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Statistics
International
| United States | 8 |
| United Kingdom | 2 |
Operational
| General Counsel | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Private companies | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Tracey McCain
- Experience
